OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
WBSNYSE68

WEBSTER FINANCIAL CORP

BanksVerified

Webster Financial's capital structure is characterized by a debt-to-equity ratio of 0.0, indicating a strong equity position relative to liabilities. The company's liquidity position is marked by a free cash flow of $278.27 million, suggesting robust cash generation from operations. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics show a return on equity (ROE) of 2.57% and a return on assets (ROA) of 0.29%, which are below the industry median for banks. This suggests that Webster Financial is underperforming in terms of capital efficiency and asset utilization compared to its peers. The company's revenue is concentrated in the Northeast, with 196 banking centers, and its segments include Commercial Banking, Healthcare Financial Services, and Consumer Banking. The Healthcare Financial Services segment, which includes HSA Bank and Ametros, is a notable differentiator in the healthcare finance space. Growth trajectory is influenced by the proposed Transaction with Banco Santander, which could lead to cost savings and synergies. However, the transaction's success is contingent on regulatory approvals and market conditions, with potential delays or termination risks. The company's outlook for the current fiscal year indicates a potential for growth, but the exact numeric deltas are not provided in the source data. Risk factors include medium dilution potential, primarily due to the proposed Transaction with Banco Santander, which involves the issuance of additional Ordinary Shares and corresponding ADSs. The risk assessment also highlights the potential for legal and regulatory proceedings, as well as the impact of macroeconomic conditions on the company's performance. Recent events include the filing of forward-looking statements and the identification of factors that could cause the company's actual results to differ from those discussed. These include risks related to the Transaction with Banco Santander, regulatory changes, and economic conditions.

30-day price · WBS(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyWEBSTER FINANCIAL CORP
ExchangeNYSE
TickerWBS
CIK0000801337
SICNational Commercial Banks
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryBanks
AI analysis

Business. Webster Financial Corporation operates as a bank holding company for Webster Bank, N.A., providing financial services through Commercial Banking, Healthcare Financial Services, and Consumer Banking segments.

Classification. Webster Financial is classified under the Banks industry within the Banking & Investment Services business sector, with a confidence level of 0.92.

Webster Financial's capital structure is characterized by a debt-to-equity ratio of 0.0, indicating a strong equity position relative to liabilities. The company's liquidity position is marked by a free cash flow of $278.27 million, suggesting robust cash generation from operations. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics show a return on equity (ROE) of 2.57% and a return on assets (ROA) of 0.29%, which are below the industry median for banks. This suggests that Webster Financial is underperforming in terms of capital efficiency and asset utilization compared to its peers. The company's revenue is concentrated in the Northeast, with 196 banking centers, and its segments include Commercial Banking, Healthcare Financial Services, and Consumer Banking. The Healthcare Financial Services segment, which includes HSA Bank and Ametros, is a notable differentiator in the healthcare finance space. Growth trajectory is influenced by the proposed Transaction with Banco Santander, which could lead to cost savings and synergies. However, the transaction's success is contingent on regulatory approvals and market conditions, with potential delays or termination risks. The company's outlook for the current fiscal year indicates a potential for growth, but the exact numeric deltas are not provided in the source data. Risk factors include medium dilution potential, primarily due to the proposed Transaction with Banco Santander, which involves the issuance of additional Ordinary Shares and corresponding ADSs. The risk assessment also highlights the potential for legal and regulatory proceedings, as well as the impact of macroeconomic conditions on the company's performance. Recent events include the filing of forward-looking statements and the identification of factors that could cause the company's actual results to differ from those discussed. These include risks related to the Transaction with Banco Santander, regulatory changes, and economic conditions.
Key takeaways
  • Webster Financial's capital structure is strong with a debt-to-equity ratio of 0.0, but its profitability metrics are below industry medians.
  • The company's revenue is concentrated in the Northeast, and its Healthcare Financial Services segment is a key differentiator.
  • The proposed Transaction with Banco Santander could lead to growth but is subject to regulatory and market risks.
  • The company faces medium dilution potential and a range of risk factors, including legal, regulatory, and macroeconomic uncertainties.
  • # RATIONALES
  • margin_outlook_rationale: The company's net interest margin is expected to remain stable, supported by its diversified loan portfolio and interest-earning assets.
  • rd_outlook_rationale: Research and development is not a significant factor for a bank like Webster Financial, but investment in technology and cybersecurity is expected to continue.
  • capex_outlook_rationale: Capital expenditures are expected to remain modest, with a focus on maintaining and upgrading existing infrastructure.
Financial snapshot
PeriodQ1 2026
CurrencyUSD
Revenue$63.7M
Gross profit
Operating income$356.8M
Net income$246.2M
R&D
SG&A
D&A$20.0M
SBC$14.0M
Operating cash flow$288.7M
CapEx$10.5M
Free cash flow$278.3M
Total assets$85.58B
Total liabilities$76.01B
Total equity$9.57B
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2025$238.0M$1.47B$1.00B$1.01B
FY2024$245.7M$1.24B$768.7M$1.37B
FY2025$245.7M$1.24B$768.7M$1.37B
FY2023$233.4M$1.24B$867.8M$938.3M
FY2024$233.4M$1.24B$867.8M$938.3M
PeriodGross %Op %Net %FCF %
FY2025
FY2024
FY2025
FY2023
FY2024
PeriodAssetsEquityCashDebt
FY2025$84.07B$9.49B
FY2024$79.03B$9.13B
FY2025$79.03B$9.13B
FY2023$74.95B$8.69B
FY2024$74.95B$8.69B
PeriodOCFCapExFCFSBC
FY2025$1.06B$49.6M$1.01B$56.8M
FY2024$1.40B$35.8M$1.37B$55.1M
FY2025$1.40B$35.8M$1.37B$55.1M
FY2023$978.6M$40.3M$938.3M$54.1M
FY2024$978.6M$40.3M$938.3M$54.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q1 2026$63.7M$356.8M$246.2M$278.3M
Q1 2026
Q3 2025$179.3M$1.11B$747.0M$706.8M
Q2 2025$120.2M$731.3M$485.8M$344.3M
PeriodGross %Op %Net %FCF %
Q1 2026
Q1 2026
Q3 2025
Q2 2025
PeriodAssetsEquityCashDebt
Q1 2026$85.58B$9.57B
Q1 2026$84.07B$9.49B
Q3 2025$83.19B$9.46B
Q2 2025$81.91B$9.34B
PeriodOCFCapExFCFSBC
Q1 2026$288.7M$10.5M$278.3M$14.0M
Q1 2026
Q3 2025$740.5M$33.7M$706.8M$41.9M
Q2 2025$365.8M$21.5M$344.3M$29.1M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$6.38B
Net cash
Current ratio
Debt/Equity0.0
ROA0.3%
ROE2.6%
Cash conversion1.2%
CapEx/Revenue16.4%
SBC/Revenue22.0%
Asset intensity0.0
Dilution ratio-1.4%
Risk assessment
Dilution riskMedium
Liquidity riskUnknown
  • Source documents mention dilution or offering risk.
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Banks · cohort 7 companies
MetricWBSActivity
Op margin560.2%560.2% medp25 560.2% · p75 560.2%bottom quartile
Net margin386.6%459.2% medp25 422.9% · p75 495.5%bottom quartile
Gross margin62.8% medp25 28.5% · p75 92.6%
CapEx / revenue16.4%2.6% medp25 1.0% · p75 12.1%top quartile
Debt / equity0.0%16.8% medp25 13.7% · p75 33.1%bottom quartile
Observations
IR observations
market data ESG controversies score100.0
market data ESG governance pillar60.0
market data ESG social pillar60.8
market data insider trading score3.0
Competitor context
JPMJPMorgan ChaseUSPeer
Derived from classification anchor Banks.
Banks, Banking & Investment Services, Financials
BACBank of AmericaUSPeer
Derived from classification anchor Banks.
Banks, Banking & Investment Services, Financials
CCitigroupUSPeer
Derived from classification anchor Banks.
Banks, Banking & Investment Services, Financials
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
SEC filingstype companyfacts · CIK 0000801337 · 1139 us-gaap concepts
2026-05-01 10:10 UTC#a2bc17bb
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 10:12 UTCJob: beac3aa1